The impact of obesity on disease activity and treatment response in rheumatoid arthritis
Published research demonstrates accelerated wound healing in skin, hair follicles, bone tissue, gastrointestinal tract lining, and animal wound models across multiple species
Retatrutide is currently undergoing large-scale Phase 3 trials (the TRIUMPH program)
Pathak D, Shields LY, Mendelsohn BA, Haddad D, Lin W, Gerencser AA, et al
Stevenson, B
A chi sono destinati questi farmaci Questi farmaci sono indicati per adulti con obesit (indice di massa corporea 30) o sovrappeso (indice di massa corporea 27) con almeno una complicanza correlata, come il diabete di tipo 2, lipertensione o la dislipidemia